Saudi Arabia RNA Therapeutics Market to Grow with a CAGR of 3.72% through 2030

Surge in research and development activities is expected to drive the Saudi Arabia RNA Therapeutics Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Saudi Arabia RNA Therapeutics Market - By Region and Competition, Forecast & Opportunities, 2030F”, the Saudi Arabia RNA Therapeutics Market stood at USD 135.69 Million in 2024 and is anticipated to grow with a CAGR of 3.72% through 2030. Initiatives taken by government based on RNA therapeutics has led to favorable market conditions for the Saudi Arabia RNA Therapeutics Market. Several factors contribute to the growth of various RNA therapeutics products.

One of the main initiatives is the investment in advanced biotechnology infrastructure. The Saudi government has been funding the establishment and expansion of state-of-the-art research and manufacturing facilities, equipped with the necessary technologies for the development of RNA-based treatments. These facilities include specialized laboratories and biomanufacturing plants that can support the production of RNA therapeutics, ensuring the Kingdom has the infrastructure needed to meet both local and international demand.

A key factor propelling the growth of R&D activities in Saudi Arabia’s RNA therapeutics market is the government’s strategic investment in biotechnology and healthcare innovation. As part of its Vision 2030 plan, the Saudi government is making substantial investments to modernize the healthcare sector, enhance medical research, and support the growth of biotechnology industries. This investment is facilitating the establishment of advanced research institutions and fostering a conducive environment for the development of RNA therapeutics.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Saudi Arabia RNA Therapeutics Market”

The Saudi Arabia RNA Therapeutics Market is segmented into product, indication, regional distribution, and company.

Based on Product, Drugs have emerged as the dominating segment in the Saudi Arabia RNA Therapeutics Market in 2024. RNA-based drugs offer the unique advantage of precision medicine. Unlike traditional small molecule drugs or biologics, RNA therapeutics can be designed to specifically target the genetic and molecular drivers of diseases. This specificity allows for more effective treatments with fewer side effects, particularly for diseases with complex and poorly understood mechanisms, such as rare genetic disorders and certain types of cancers. The potential to personalize treatments for individual patients, based on their genetic makeup, has made RNA drugs highly attractive to healthcare providers and pharmaceutical companies in Saudi Arabia.

Based on Region, Western have emerged as the fastest growing region in the Saudi Arabia RNA Therapeutics Market in 2024. The Western region’s proximity to major international airports, ports, and commercial hubs makes it an ideal location for establishing partnerships with global pharmaceutical companies and research institutions. Jeddah, as a key gateway to international markets, has attracted numerous collaborations between local healthcare institutions and global players in RNA-based therapeutics. These partnerships have facilitated the exchange of knowledge, resources, and technology, enabling the rapid development and adoption of RNA therapies in the region. Additionally, multinational companies are more likely to establish their regional headquarters and research facilities in this region, further fueling growth.

Major companies operating in Saudi Arabia RNA Therapeutics Market are:

• Pfizer Scientific Technical Limited Company
• Biogen Arabia Limited
• Novartis Saudi Arabia
• Moderna, Inc.
• Tabuk Pharmaceuticals

Download Free Sample Report

Customers can also request for 10% free customization on this report

“One of the major challenges in RNA therapeutics is the efficient and targeted delivery of RNA molecules to the right cells or tissues in the body. Nanotechnology offers solutions in the form of nanocarriers, such as liposomes, nanoparticles, and nanostructured lipid carriers, which can encapsulate RNA molecules and protect them from degradation. These nanocarriers enable more effective and precise delivery, improving the therapeutic outcomes of RNA-based treatments. In Saudi Arabia, research institutions and biotech firms are increasingly leveraging nanotechnology to develop advanced delivery systems that enhance the bioavailability and therapeutic potential of RNA molecules”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Saudi Arabia RNA Therapeutics Market By Product (Vaccines, Drugs, Others), By Indication (Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others), By Region and Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Saudi Arabia RNA Therapeutics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Saudi Arabia RNA Therapeutics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]